Publications by authors named "Kiyotsugu Iede"

Article Synopsis
  • Increased skeletal muscle mass during AG (nab-paclitaxel plus gemcitabine) treatment may have significant clinical implications for patients with advanced pancreatic cancer (APC), particularly in relation to their ability to receive second-line chemotherapy.
  • A study analyzed 67 APC patients who underwent AG treatment between 2015 and 2021, comparing patients who went on to receive second-line chemotherapy with those who received supportive care after treatment.
  • Key findings indicated that better performance status and increased muscle mass were linked to higher chances of receiving subsequent chemotherapy, suggesting that maintaining or increasing muscle mass during treatment could be beneficial.
View Article and Find Full Text PDF
Article Synopsis
  • An 80-year-old woman was diagnosed with anal canal cancer after presenting with melena and underwent robot-assisted surgery that confirmed stage IIIb cancer.
  • A year later, she developed local recurrence in the perineum and was also found to have ascending colon cancer, prompting additional surgeries including laparoscopic resections.
  • Post-surgery, her condition improved, and there were no signs of recurrence for six months.
View Article and Find Full Text PDF

We report a case of a female in her fifties with early appendiceal adenocarcinoma coexisting with high-grade appendiceal mucinous neoplasm(HAMN)with a review of the literature. The patient presented to our hospital because of an enlarged appendix noted by contrast-enhanced CT performed for hematuria. Contrast-enhanced CT showed that the appendix had swollen to 10 mm and mucus had accumulated inside, which had no evidence of obvious malignancy.

View Article and Find Full Text PDF

Although the antitumor effects of antihypertensive drugs for patients with advanced pancreatic cancer (APC) have been investigated, their efficacy remains unclear. Previous studies suggest that hypertensive (HT) patients with APC are significantly older than non-HT patients with APC, and that other major baseline differences in patient characteristics which may affect prognosis exist between HT and non-HT patients. It is also possible that antihypertensive drugs lack antitumor activity.

View Article and Find Full Text PDF

Objective: Second-line (2L) chemotherapy is important for improved survival in patients with advanced pancreatic cancer (APC). However, approximately half of patients with APC do not receive 2L chemotherapy because of disease progression or adverse events. Baseline factors predictive of the receipt of 2L chemotherapy remain unknown.

View Article and Find Full Text PDF

The patient was 80s woman, whose chief complaint of fever and abdominal pain. She visited our hospital, and further evaluation revealed sigmoid colon cancer invading the uterus and abdominal wall. The pooling of pus in the uterus was formed and we diagnosed as pyometra.

View Article and Find Full Text PDF
Article Synopsis
  • * Diagnosis revealed rectal cancer invading the prostate with metastasis to lymph nodes, classified as T4bN3M0, Stage Ⅲc.
  • * After receiving chemotherapy (4 courses of CAPOX plus bevacizumab), the patient's condition improved, and he underwent robotic pelvic surgery, remaining cancer-free for five months post-treatment.
View Article and Find Full Text PDF

A 42-year-old woman visited our hospital complaining of fever and diarrhea. She had abdominal swelling and muscular defense. CT revealed a lobulated tumor occupying the lower abdomen.

View Article and Find Full Text PDF

Purpose: The peripancreatic arterial system forms various arterial arcades and collateral branches; therefore, it stands to reason that the arterial supply into the pancreatic head region should be controlled as a whole peripancreatic arterial arcade rather than as the three major supplying arteries during isolated pancreatoduodenectomy (PD). We investigated the clinical importance of early control of the whole peripancreatic arterial arcade during PD.

Methods: The subjects of this retrospective study were 63 consecutive patients who underwent PD via a mesenteric approach at our hospital between October, 2014 and February, 2017.

View Article and Find Full Text PDF

We report a case of a male in his sixties with appendiceal cancer who underwent radical resection following CAPOX plus bevacizumab neoadjuvant chemotherapy. The patient presented to our hospital with a chief complaint of chronic low abdominal pain. Contrast-enhanced CT before neoadjuvant chemotherapy revealed an inhomogeneous tumor in the ileocecal region.

View Article and Find Full Text PDF

An 81-year-old female who suffered from headache and general fatigue was diagnosed multiple liver abscesses by abdominal computed tomography(CT). Antibiotics and percutaneous transhepatic abscess drainage(PTAD)were performed, liver abscesses were improved. During the treatment, followed abdominal CT indicated lower rectal tumor.

View Article and Find Full Text PDF

Background: Second-line (2L) chemotherapy after nab-paclitaxel plus gemcitabine (AG) is important for improving the survival of patients with advanced pancreatic cancer (APC). However, many patients fail to receive 2L chemotherapy because of rapid disease progression. Therefore, early recognition of any ineffectiveness during AG might lead to an increased induction rate of 2L chemotherapy.

View Article and Find Full Text PDF

Background: Bridge to surgery (BTS) using a self-expandable metallic stent (SEMS) for the treatment of obstructive colorectal cancer improves the patient's quality of life. This study aimed to examine prognostic factors of obstructive colorectal cancer.

Methods: We analyzed stage II-III resectable colon cancer cases (Cur A) retrospectively registered between January 2005 and December 2017.

View Article and Find Full Text PDF

Background: Second-line (2 L) chemotherapy is important for improved survival. However, the efficacy of S-1 after nab-paclitaxel plus gemcitabine (AG) for advanced pancreatic cancer (APC) remains unclear.

Aim: We retrospectively investigated the clinical impact of S-1 after AG.

View Article and Find Full Text PDF

A 64-year-old man presented with the chief complaint of weakness in the left half of his body. He fell down on the road while riding a bicycle and was transported to the emergency room. A contrast-enhanced brain MRI revealed a 28mm ringshaped mass in the right frontal lobe.

View Article and Find Full Text PDF

A 94-year-old woman, who had been treated for multiple colon cancers 4 years ago, complained of umbilicus induration and had been followed up in a previous hospital with a diagnosis of periumbilical inflammation. Four years and 3 months postoperatively, the umbilical induration was enlarged, and umbilical metastasis of adenocarcinoma was diagnosed on biopsy. Umbilical resection was performed, and multiple peritoneal metastases were revealed.

View Article and Find Full Text PDF

Background: Early ligation of the inferior pancreatoduodenal artery has been advocated to reduce blood loss during pancreatoduodenectomy. However, the impact of early ligation of the dorsal pancreatic artery (DPA) remains unclear. This study was performed to investigate the clinical implications of early ligation of the DPA.

View Article and Find Full Text PDF

Background: Gastric venous congestion and bleeding in association with total pancreatectomy (TP) were evaluated.

Methods: Thirty-eight patients of TP were retrospectively analyzed. TP was classified as TP with distal gastrectomy (TPDG), pylorus-preserving TP (PPTP), subtotal stomach-preserving TP (SSPTP), and TP with segmental duodenectomy (TPSD).

View Article and Find Full Text PDF

Background: Superior mesenteric vein-portal vein confluence resection combined with pancreatoduodenectomy (SMPVrPD) is occasionally required for resection of pancreatic head tumors. It remains unclear whether such situations require splenic vein (SV) reconstruction for decompression of left-sided portal hypertension (LSPH).

Methods: The data from 93 of 104 patients who underwent pancreatoduodenectomy (PD) for pancreatic head malignancies were reviewed.

View Article and Find Full Text PDF